Gold nanoparticles enter rat ovarian granulosa cells and subcellular organelles, and alter In-Vitro estrogen accumulation

Journal of Reproduction and Development

Volumn 55, Issue 6, 2009, Pages 685-690

  Stelzer, Rosemary ^a   Hutz, Reinhold J ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Estrogen; Granulosa cells; Nanoparticles; Steroidogenesis; Transmission electron microscopy

Indexed keywords

ESTRADIOL; GOLD; METAL NANOPARTICLE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL MEMBRANE; CELL ORGANELLE; CELL VACUOLE; CHEMISTRY; DRUG EFFECT; FEMALE; GRANULOSA CELL; METABOLISM; MITOCHONDRION; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TIME; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; ESTRADIOL; FEMALE; GOLD; GRANULOSA CELLS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; ORGANELLES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VACUOLES;

RATTUS;

EID: 74349122190     PISSN: 09168818     EISSN: 13484400     Source Type: Journal    
DOI: 10.1262/jrd.20241     Document Type: Article

References (39)

1. Salata OV. Applications of nanoparticles in biology and medicine. J Nanobiotechnol 2004; 2: 3.
2. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci 2001; 90: 1927-1936.
3. Hoet PHM, Bruske-Hohlfeld I, Salata OV. Nanoparticles-known and unknown health risks. J Nanobiotechnol 2004; 2: 12-20.
4. Kam NWS, Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 2005; 127: 6021-6026.
5. Paciotti GF, Myer L, Weinrich D, Goia D, Pavel N, McLaughlin RE, Tamarkin L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004; 11: 169-183.
6. Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2005; 2: 1743-1878.
7. Parak WJ, Gerion D, Pellegrino T, Zanchet D, Micheel C, Williams SC, Boudreau R, Le Gros MA, Larabell CA, Alivisatos AP. Biological applications of colloidal nanocrystals. Nanotechnol 2003; 14: R15-R27.
8. Rosi NL, Giljohann DA, Thaxton S, Lytton-Jean AKR, Han MS, Mirkin CA. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006; 312: 1027-1030.
9. Kreyling W, Semmler M, Erbe R, Mayer P, Takenaka S, Schulz H, Oberdorster G, Ziesenis A. Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health 2002; 65A: 1513-1530.
10. Lam C, James JT, McCluskey R, Hunter RL. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 2004; 77: 126-134.
11. Tasat D, Gugliemotti MB, Cabrini RL. Titanium transport through the bloodstream: an experimental study on rats. J Mater Sci Mater Med 2003; 14: 1099-1103.
12. Skukla R, Bansal V, Chaudhary M, Basn A, Bhonde RR, Sastry M. Biocompatability of gold nanoparticles and their endocytotic fate inside the cellular compartment a microscopic overview. Langmuir 2005; 21: 10644-10654.
13. Wiley C. Nanotechnology and molecular homeostasis. J Am Geriat Soc 2005; 53: S295-S298.
14. Yamawaki H, Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol 2006; 290: C1495-C1502.
15. Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113: 823-839.
16. Chithrani DB, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006; 6: 662-668.
17. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, Prasad PN. Optical tracking of organically modified silica nanoparticles as DNA carriers: A nonviral nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 2005; 102: 279-284.
18. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler M, Hof VIM, Heyder J, Gehr P. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 2005; 113: 1555-1560.
19. Dasmahapatra AK, Wimpee BA, Trewin AL, Wimpee CF, Ghorai JK, Hutz RJ. Demonstration of 2,3,7,8-tetrachlorodibenzo-p-dioxin attenuation of P450 steroidogenic enzyme mRNAs in rat granulosa cell in vitro by competitive reverse transcriptase polymerase chain reaction assay. Mol Cell Endocrinol 2000; 164: 5-18.
20. Heimler I, Rawlins RG, Owen H, Hutz RJ. Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and induces apoptosis of luteinized granulosa cells. Endocrinol 1998; 139: 4373-4379.
21. Heimler I. Perturbation of ovarian function by 2,3,7,8-tetrachlorodibenzo-P-dioxin. Dissertation for requirements for the degree of doctor of philosophy in biological Sciences at the University of Wisconsin-Milwaukee 1997.
22. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann M. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005; 88: 412-419.
23. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, MacNee W, Stone V. Combustion-derived nanoparticles: A review of their toxicology following inhalation exposure. Part Fibre Toxicol 2005; 2: 1743-1770.
24. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006; 114: 165-172.
25. Hayat MA. Principles and Techniques of Electron Microscopy Biological Applications. 4th ed. New York: Cambridge University Press; 2000.
26. Chen Y, Xue Z, Zheng D, Xia K, Zhao Y, Liu T, Long Z, Xia J. Sodium chloride modified silica nanoparticles as a non-viral vector with a high efficiency of DNA transfer into cells. Curr Gene Ther 2003; 3: 273-279.
27. Prina-Mello A, Diao Z, Coey JMD. Internalization of ferromagnetic nanowires by different living cells. J Nanobiotechnol 2006; 4: 9.
28. Kashiwada S. Distribution of nanoparticles in the see-through Medaka (Oryzias latipes). Environ Health Perspect 2006; 114: 1697-1702.
29. Keegan GM, Learmonth ID, Case CP. Orthopaedic metals and their potential toxicity in the arthroplasty patient. J Bone Jt Surg 2007; 89: 567-573.
30. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006; 311: 622-627.
31. Borm PJA, Robbins D, Haubold S, Kuhlbusch T, Fissan H, Donaldson K, Schins R, Stone V, Kreyling W, Lademann J, Krutmann J, Warheit D, Oberdorster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 2006; 3: 1186-1221.
32. Richards JS. Perspective: The ovarian follicle-a perspective in 2001. Endocrinol 2001; 142: 2184-2193.
33. Goodman MH. Basic Medical Endocrinology. 2nd ed. New York: Raven Press, 1994.
34. Hadley ME. Endocrinology. 2nd ed. New Jersey: Prentice Hall, 1988.
35. Jamnongjit M, Hammes SR. Ovarian steroids: the good, the bad, and the signals that raise them. Cell Cycle 2006; 5: 1178-1183.
36. Amsterdam A, Knecht M, Catt KJ. Hormonal regulation of cytodifferentiation and intercellular communication in cultured granulosa cells. Proc Natl Acad Sci USA 1981; 78: 3000-3004.
37. Amsterdam A, Berkowitz A, Nimrod A, Kohen F. Aggregation of luteinizing hormone receptors in granulosa cells: A possible mechanism of desensitization to the hormone. Proc Natl Sci USA 1980; 77: 3440-3444.
38. Dive C, Yoshida TM, Simpson DJ, Marrone BL. Flow cytometric analysis of steroidogenic organelles in differentiating granulosa cells. Biol Reprod 1992; 47: 520-527.
39. Guillette LJ. Endocrine disrupting contaminants-beyond the dogma. Environ Health Perspect 2006; 114 (Suppl 1): 9-12.